Close | |
![]() |
|
Table 2: Oral glucose tolerance test, homeostasis model assessment-insulin resistance, area under the curve and lipid profile in Group A (spironolactone) and Group B (spironolactone and dietary induced weight-loss) at baseline and alter treatment |
|